Le Lézard
Classified in: Health, Science and technology
Subject: Sales

Biogennix Reports Record Sales Month for July


Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone grafting products used for bone fusion procedures, announced today that its July performance was the best in the company's history.

"The momentum we have developed over the year really culminated into our best sales performance to date," said Chris MacDuff, Biogennix's CEO. "With a dedicated focus by our regional sales managers, increased marketing initiatives and, most importantly, our distributor partner efforts, we have been able to significantly expand our sales. Our Morpheustm product is fast becoming the standard of effectiveness and ease of use in the bone graft products space and there is yet more to come from Biogennix very soon."

MacDuff also noted that to accommodate the year's growth and increasing demand for its products, Biogennix is in the process of increasing its manufacturing capabilities, further expanding its sales team, and boosting its R&D capabilities.

The majority of Biogennix's steady growth is attributed to increases in sales of the company's novel bone grafting products, Morpheus and osteoSPANtm, both of which are resorbable, osteoconductive scaffolds ideally suited for bone regeneration. The Morpheus product is a moldable version of osteoSPAN, which combines the granules with an organic binder, providing optimal handling characteristics for surgeons.

Biogennix is a leading developer of osteobiologic products specifically designed for spine fusion and bone trauma. The company is led by a team of scientists and industry veterans committed to delivering unique products for bone regeneration. Biogennix designs, manufactures and distributes all of its products from its Irvine facilities.

Biogennixtm is a fully-integrated osteobiologics company headquartered in Irvine which develops, manufactures, and distributes proprietary bone grafting products used in bone fusion procedures. Biogennix is committed to advancing technology behind natural bone grafting solutions, delivering outstanding quality with exceptional value, and customer-focused excellence. Learn more at biogennix.com.


These press releases may also interest you

at 03:05
Manhattan Associates Inc. , a global leader in supply chain commerce solutions, announced today that it has been named a Leader in the Gartner Magic Quadrant for Transportation Management Systems for the sixth consecutive year. Manhattan Active®...

at 03:05
On April 13, 2024, the 2024 ASC Student Supercomputer Challenge (ASC24) Finals drew to a close at Shanghai University after five days of intense competition. Peking University emerged as the undisputed overall champion, securing their place in ASC...

at 03:05
Edge Impulse, the leading platform for building, refining and deploying machine learning models to edge devices, has unveiled a novel technology for unlocking visual anomaly detection on any edge device, from NVIDIA GPUs to Arm MCUs, through the...

at 03:05
LatticeFlow AI, the leading platform empowering Artificial Intelligence (AI) teams to build performant, safe, and trustworthy AI solutions, proudly announces that it has joined the U.S. AI Safety Institute Consortium (AISIC). LatticeFlow AI...

at 03:05
In addition to the clear risks, such as an increase in fraud, attracting new foreign customers presents less apparent challenges, including the absence of standardized documentation and language barriers. These are the results of a global survey...

at 03:01
A new global survey from Norton, a consumer Cyber Safety brand of Gentm , has shed light on a new way people are looking to incorporate AI into their lives -- online dating. Two thirds (64%) of current online daters are interested in using AI as...



News published on and distributed by: